Hearing Loss and Cardiovascular Disease Risk Profiles: Data from the Hispanic Community Health Study/Study of Latinos
- 1 October 2022
- journal article
- research article
- Published by American Academy of Audiology in Journal of the American Academy of Audiology
- Vol. 33 (9) , 445-459
Abstract
Background Individual cardiovascular disease (CVD) risk factors (RFs) have been associated with hearing loss (HL). The relationship to aggregate risk is poorly understood and has not been explored in the Hispanic/Latino population. Purpose The aim of this study was to characterize the association between aggregate CVD RF burden and hearing among Hispanics/Latinos. Research Design Cross-sectional examination. Study Sample Participants (18‐74 years; n = 12,766) in the Hispanic Community Health Study/Study of Latinos. Data Collection and Analysis Thresholds (0.5‐8 kHz) were obtained, and HL was defined dichotomously as pure-tone average (PTA0.5,1, 2,4) > 25 dB HL. Optimal CVD risk burden was defined as follows: systolic blood pressure (SBP) < 120 mm Hg and diastolic blood pressure (DBP) < 80 mm Hg; total cholesterol < 180 mg/dL; nonsmoking; and no diabetes. Major CVD RFs were diabetes, currently smoking, SBP >160 or DBP > 100 mm Hg (or antihypertensives), and total cholesterol > 240 mg/dL (or statins). Thresholds were estimated by age (18‐44 and ≥45 years) and sex using linear regression. The association between CVD risk burden and HL was assessed using multivariable logistic regression. Models were adjusted for age, sex, Hispanic/Latino background, center, education, income, alcohol use, body mass index, and noise exposure. Results In the target population, 53.03% were female and 18.81% and 8.52% had all RFs optimal and ≥2 major RFs, respectively. Elevated BP (SBP 120‐139 mm Hg or DBP 80‐89 mm Hg) was associated with HL in females < 45 years (odds ratio [OR], 2.18; 95% confidence interval [CI], 1.14‐4.16). Diabetes (OR, 1.37; 95% CI, 1.01‐1.84) and tobacco smoking (OR, 1.44; 95% CI, 1.03‐2.01) were associated with HL in females ≥ 45 years. The odds of HL were higher for females ≥ 45 years with ≥2 RFs versus those with all RFs optimal (OR, 1.99; 95% CI, 1.12‐3.53). Elevated BP (SBP 140‐159 mm Hg or DBP 90‐99 mm Hg), but not aggregate risk burden, was associated with HL in males ≥ 45 years (OR, 1.49; 95% CI, 1.02‐2.19). No relationships with major CVD RFs were significant in males < 45 years. Conclusions HL is associated with elevated BP in females < 45 years, with diabetes and hypertension in males ≥ 45 years, and with diabetes, smoking, and having ≥2 major CVD RFs in females ≥ 45 years. Future studies are needed to examine if these factors are associated with incident HL.Keywords
This publication has 47 references indexed in Scilit:
- Relationship of stroke risk and hearing loss in African Americans: The Jackson Heart StudyThe Laryngoscope, 2017
- Addressing Estimated Hearing Loss in Adults in 2060JAMA Otolaryngology–Head & Neck Surgery, 2017
- Declining Prevalence of Hearing Loss in US Adults Aged 20 to 69 YearsJAMA Otolaryngology–Head & Neck Surgery, 2017
- Hearing Impairment Prevalence and Associated Risk Factors in the Hispanic Community Health Study/Study of LatinosJAMA Otolaryngology–Head & Neck Surgery, 2015
- Is type 2 diabetes mellitus associated with alterations in hearing? A systematic review and meta‐analysisThe Laryngoscope, 2013
- Diabetes‐related changes in hearingThe Laryngoscope, 2009
- Prevalence of Hearing Loss and Differences by Demographic Characteristics Among US AdultsData From the National Health and Nutrition Examination Survey, 1999-2004Archives of internal medicine (1960), 2008
- Effects of Type 2 Diabetes Mellitus on Cochlear Structure in HumansJAMA Otolaryngology–Head & Neck Surgery, 2006
- Cigarette Smoking and Hearing LossJAMA, 1998
- The Relation of Hearing in the Elderly to the Presence of Cardiovascular Disease and Cardiovascular Risk FactorsJAMA Otolaryngology–Head & Neck Surgery, 1993